Close

Prof Pontiano Kaleebu

Professor of Immunovirology*

United Kingdom

Affiliations

MRC/UVRI and LSHTM Uganda Research Unit

Selected Publications

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.
Man-Lik Choi, E; Abu-Baker Mustapher, G; Omosa-Manyonyi, G; Foster, J; Anywaine, Z; Musila Mutua, M; Ayieko, P; Vudriko, T; Ann Mwangi, I; Njie, Y; Ayoub, K; Mundia Muriuki, M; Kasonia, K; Edward Connor, N; Florence, N; MANNO, D; Katwere, M; McLean, C; Gaddah, A; Luhn, K; Lowe, B; GREENWOOD, B; Robinson, C; Anzala, O; KALEEBU, P; ... EBL2010 Study Team,
2023
Vaccine
Bacterial microbiome and host inflammatory gene expression in foreskin tissue.
Maust, BS; Petkov, S; Herrera, C; Feng, C; Brown, BP; Lebina, L; Opoka, D; Ssemata, A; Pillay, N; Serwanga, J; Seatlholo, P; Namubiru, P; Odoch, G; Mugaba, S; Seiphetlo, T; Gray, CM; Kaleebu, P; Webb, EL; Martinson, N; Chiodi, F; Fox, J; Jaspan, HB; CHAPS team,;
2023
Heliyon
Molecular characterization of the 2022 Sudan virus disease outbreak in Uganda.
Balinandi, S; Whitmer, S; Mulei, S; Nassuna, C; Pimundu, G; Muyigi, T; Kainulainen, M; Shedroff, E; Krapiunaya, I; Scholte, F; Nyakarahuka, L; Tumusiime, A; Kyondo, J; Baluku, J; Kiconco, J; Harris, JR; Ario, AR; Kagirita, A; Bosa, HK; Ssewanyana, I; Nabadda, S; Mwebesa, HG; Aceng, JR; Atwine, D; Lutwama, JJ; ... Klena, JD.
2023
Journal of virology
Recommendations on data sharing in HIV drug resistance research.
Inzaule, SC; Siedner, MJ; Little, SJ; Avila-Rios, S; Ayitewala, A; Bosch, RJ; Calvez, V; Ceccherini-Silberstein, F; Charpentier, C; Descamps, D; Eshleman, SH; Fokam, J; Frenkel, LM; Gupta, RK; Ioannidis, JP A; KALEEBU, P; Kantor, R; Kassaye, SG; Kosakovsky Pond, SL; Kouamou, V; Kouyos, RD; Kuritzkes, DR; Lessells, R; Marcelin, A-G; Mbuagbaw, L; ... Shafer, RW.
2023
PLoS medicine
Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection.
Ssali, I; Mugaba, S; Watelo, AK; Bemanzi, J; Katende, JS; Oluka, GK; Ankunda, V; Baine, C; Kato, L; COVID-19 Immunoprofiling Team,; Onyachi, N; Muwanga, M; Jjuuko, M; Kayiwa, J; Nsereko, C; Auma, BO; Weiskopf, D; Sette, A; Lutalo, T; Musenero, M; KALEEBU, P; SERWANGA, J;
2023
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
McLaren, PJ; Porreca, I; Iaconis, G; Mok, HP; Mukhopadhyay, S; Karakoc, E; Cristinelli, S; Pomilla, C; Bartha, I; Thorball, CW; Tough, RH; Angelino, P; Kiar, CS; Carstensen, T; FATUMO, S; Porter, T; Jarvis, I; Skarnes, WC; Bassett, A; DeGorter, MK; Sathya Moorthy, MP; Tuff, JF; Kim, E-Y; Walter, M; Simons, LM; ... Fellay, J.
2023
Nature
HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfection.
Obuku, AE; Lugemwa, JK; ABAASA, A; Joloba, M; Ding, S; Pollara, J; Ferrari, G; Harari, A; Pantaleo, G; KALEEBU, P;
2023
BMC immunology
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.
Global Cardiovascular Risk Consortium,; Magnussen, C; Ojeda, FM; Leong, DP; Alegre-Diaz, J; Amouyel, P; Aviles-Santa, L; De Bacquer, D; Ballantyne, CM; Bernabé-Ortiz, A; Bobak, M; Brenner, H; Carrillo-Larco, RM; De Lemos, J; Dobson, A; Dörr, M; Donfrancesco, C; Drygas, W; Dullaart, RP; Engström, G; Ferrario, MM; Ferrières, J; De Gaetano, G; Goldbourt, U; Gonzalez, C; ... Blankenberg, S.
2023
The New England journal of medicine
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.
KITONSA, J; Kamacooko, O; RUZAGIRA, E; Nambaziira, F; ABAASA, A; SERWANGA, J; Gombe, B; Lunkuse, J; Naluyinda, H; Tukamwesiga, N; Namata, T; Kigozi, A; Kafeero, P; Basajja, V; Joseph, S; Pierce, BF; Shattock, R; KALEEBU, P;
2023
Human vaccines & immunotherapeutics
Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda.
KITONSA, J; KANSIIME, S; Kusemererwa, S; Onyango, M; Nayiga, B; Kabarambi, A; Mugisha, JO; KALEEBU, P; RUZAGIRA, E; PrEPVacc Study Group,;
2023
Global health action
See more information